Ringer's solution

DRUG9 trials

Conditions

COVID-19Cesarean Section ComplicationsCoronary Heart DiseaseEye Diseases corneal endothelial changesJaundice, ObstructiveJaundice; MalignantMuscle AtrophyPeritonitis

Phase 2

Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery

CompletedNCT01794884

Yuejiang LiuCoronary Heart Disease, Rheumatic Heart Disease

Start: 2013-01-31End: 2014-03-31Updated: 2014-05-28

Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears

Active, not recruitingNCT03332238

Hospital for Special Surgery, New YorkMuscle Atrophy, Rotator Cuff Tear, Tendon Tear

Start: 2019-07-01End: 2026-07-23Target: 56Updated: 2025-11-25

The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section

CompletedNCT03833895

China International Neuroscience InstitutionCesarean Section Complications

Start: 2019-02-20End: 2019-09-02Updated: 2020-02-10

Phase 3

Remaxol® in Malignant Mechanical Jaundice

CompletedNCT03416062

POLYSAN Scientific & Technological Pharmaceutical CompanyJaundice; Malignant

Start: 2017-04-03End: 2020-03-04Updated: 2020-07-10

Remaxol® in Mechanical Jaundice of Non-malignant Origin

CompletedNCT03418935

POLYSAN Scientific & Technological Pharmaceutical CompanyJaundice, Obstructive

Start: 2017-04-03End: 2020-04-13Updated: 2020-07-14

Phase 4

The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds

CompletedNCT01153620

B. Braun Ltd. Centre of Excellence Infection ControlWounds

Start: 2010-08-31End: 2011-01-31Updated: 2012-04-06

Unknown Phase

Comparison of endothelial cell changes by specular microscopy between Ringers and Ringer¿s Lactate during Phacoemulsification

Active, not recruitingPACTR201711002708423

AuthorsEye Diseases corneal endothelial changes

Start: 2017-05-01Target: 100Updated: 2026-01-27

Lavage With Super-Oxidized Solution for Secondary Peritonitis

RecruitingNCT05050253

Insel Gruppe AG, University Hospital BernPeritonitis

Start: 2023-03-21End: 2025-04-30Target: 200Updated: 2024-01-11

Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19

CompletedNCT05172180

POLYSAN Scientific & Technological Pharmaceutical CompanyCOVID-19

Start: 2020-12-01End: 2021-04-01Updated: 2024-12-19

Related Papers

Effects of continuous infusion of phenylephrine vs. norepinephrine on parturients and fetuses under LiDCOrapid monitoring: a randomized, double-blind, placebo-controlled study

BMC Anesthesiology2020-09-0718 citations